ROCKVILLE, Md., April 9, 2007--GlaxoSmithKline recently issued a “Dear Pharmacy Professional” letter to raise awareness of an isolated, but potentially serious, apparent tampering incident involving Ziagen and Combivir tablets for treatment of HIV. The complete text of the letter follows.
